1.054
IF5
1.150
IF
Q3
JCR
1.7
CiteScore
0.396
SJR
Q2
SJR
40
MNiSW
148.75
ICV
ORIGINAL PAPER
 
CC-BY-NC 4.0
 
 

Effects of opioid and cholinergic receptors inhibition on the intestine hormones concentration and release in rats

K. Jaszcza 1,  
C. G. Scanes 2,  
M. Capcarova 3,  
 
1
University of Agriculture in Krakow, Department of Animal Physiology and Endocrinology, Al. Adama Mickiewicza 24/28, 30-059 Kraków, Poland
2
University of Arkansas, Centre of Excellence for Poultry Science Fayetteville, AR 72701, 479-575-2000, USA
3
Slovak University of Agriculture in Nitra, Department of Animal Physiology, Faculty of Biotechnology and Food Sciences, Tr. A. Hlinku 2, 949 76 Nitra, Slovak Republic
J. Anim. Feed Sci. 2020;29(3):266–275
Publication date: 2020-09-30
KEYWORDS
TOPICS
ABSTRACT
The aims of the study were: 1. to evaluate the in vivo interaction of opioid and cholinergic receptors in the regulation of Met-enkephalins (native and total) and ghrelin concentrations in the rat intestine; 2. to explore the association of opioids, muscarinic and nicotinic receptors in the regulation of in vitro secretion of peptidergic hormones such as Met-enkephalin, ghrelin, gastrin and somatostatin from rat intestine. Two experiments were performed on adult, male Wistar rats: 1. in in vivo experiment animals received a single intraperitoneal injection of NaCl (control), naltrexone (opioid receptor antagonist), atropine (muscarinic receptor antagonist) or hexamethonium (nicotinic receptor antagonist), and Met-enkephalins concentration and expression of mRNA for proenkephalin, and ghrelin concentration were measured in the intestine; 2. in in vitro experiments above receptors antagonists were added to tissue culture alone or in combination; native Met-enkephalin, ghrelin, gastrin and somatostatin concentrations were measured in the medium. In vivo inhibition of receptors increased the concentration of total Met-enkephalin and potentiated the expression of mRNA for proenkephalin. Ghrelin concentration was increased by naltrexone and decreased by atropine. In vitro secretion of Met-enkephalin was decreased by both cholinergic receptor antagonists but this effect was fully reversed by naltrexone. Ghrelin and gastrin release from the intestine was increased by all three antagonists given alone; in vitro somatostatin release from the intestine was attenuated by receptor antagonists given alone or in combination. The obtained results clearly showed the interaction of opioids and acetylcholine in the regulation of synthesis, concentration and release of peptidergic hormones from the rat intestine.
ACKNOWLEDGEMENTS
The study was supported by University of Agriculture in Krakow (grant No. Sub. 020002-D015).
CORRESPONDING AUTHOR
K. Pierzchała-Koziec   
Department of Animal Physiology and Endocrinology, University of Agriculture in Kraków
 
REFERENCES (34):
1. Abrams P., Andersson K.E., Buccafusco J.J., Chapple C., de Groat W.C., Fryer A.D., Kay G., Laties A., Nathanson N.M., Pasricha P.J., Wein A.J., 2006. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br. J. Pharmacol. 148, 565–578, https://doi.org/10.1038/sj.bjp....
2. Albuquerque E.X., Pereira E.F., Alkondon M., Rogers S.W., 2009. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 89, 73–120, https://doi.org/10.1152/physre....
3. Altarifi A.A., Bethany D., Karan H. Muchhala K.H., Blough B.E., Akbarali H., Negus S.S., 2017. Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function and abuse liability in rodents. J. Psychopharmacol. 31, 730–739, https://doi.org/10.1177/026988....
4. AVMA (American Veterinary Medical Association) Guidelines for the Euthanasia of Animals: 2020 Edition. Version 2020.0.1. Schaumburg, IL (USA).
5. Copps J., Murphy R.F., Lovas S., 2009. The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers. Protein Pept. Lett. 16, 1504–1518, https://doi.org/10.2174/092986....
6. Dupak R., Jaszcza K., Kalafova A., Schneidgenova M., Ivanisova E., Tokarova K., Brindza J., Capcarova M., 2020. Characterization of compounds in Cornelian cherry (Cornus mas L.) and its effect on interior milieu in ZDF. Emir. J. Food Agric. 32, 368–375, https://doi.org/10.9755/ejfa.2...
7. Dyaczyński M., Drożdż M., Wylężek L., Scanes C.G., Rzepa A., Pierzchała-Koziec K., 2020. Opioid-like peptides and ghrelin mitigation of bariatric results depends on obesity level. Endokrynol. Pol. 71, 27–33, https://doi.org/10.5603/EP.a20....
8. Dyaczyński M., Scanes C.G., Koziec H., Pierzchała-Koziec K., 2018. Endocrine implications of obesity and bariatric surgery. Endokrynol. Pol. 69, 574–597, https://doi.org/10.5603/EP.201....
9. Dziedzic B., Zgórzyńska E., Bewicz-Binkowska D., Walczewska A., 2019. A diet rich in menhaden oil has the hypolipidemic effect but increases plasma glucose and insulin levels in rats. J. Anim. Feed Sci. 28, 62–68, https://doi.org/10.22358/jafs/....
10. Foong J.P., Hirst C.S., Hao M.M., McKeown S.J., Boesmans W., Young H.M., Bornstein J.C., Vanden Berghe P., 2015. Changes in nicotinic neurotransmission during enteric nervous system development. J. Neurosci. 35, 7106–7115, https://doi.org/10.1523/JNEURO....
11. Galligan J.J., Sternini C., 2017. Insights into the role of opioid receptors in the GI tract: experimental evidence and therapeutic relevance. Handb. Exp. Pharmacol. 239, 363–378, https://doi.org/10.1007/164_20....
12. Goldspink D.A., Reimann F., Gribble F.M., 2018. Models and tools for studying enteroendocrine cells. Endocrinology 159, 3874–3884, https://doi.org/10.1210/en.201....
13. Gribble F.M., Reimann F., 2019. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat. Rev. Endocrinol. 15, 226–237, https://doi.org/10.1038/s41574....
14. Herosimczyk A., Lepczyński A., Ożgo M., Barszcz M., Marynowska M., Tuśnio A., Taciak M., Markulen A., Skomiał J., 2018. Proteome changes in ileal mucosa of young pigs resulting from different levels of native chicory inulin in the diet. J. Anim. Feed Sci. 27, 229–237, https://doi.org/10.22358/jafs/....
15. Holzer P., 2009. Opioid receptors in the gastrointestinal tract. Regul. Pept. 155, 11–17, https://doi.org/10.1016/j.regp....
16. Impicciatore M., Walsh J.H., Grossman M.I., 1977. Low doses of atropine enhance serum gastrin response to food in dogs. Gastroenterology 72, 995–996, https://doi.org/10.1016/S0016-....
17. Kapp-Bitter A.N., Dickhoefer U., Suglo E., Baumgartner L., Kreuzer M., Leiber F., 2020. Graded supplementation of chestnut tannins to dairy cows fed protein-rich spring pasture: effects on indicators of protein utilization. J. Anim. Feed Sci. 29, 97–104, https://doi.org/10.22358/jafs/....
18. Kokrashvili Z., Rodriguez D., Yevshayeva V., Zhou H., Margolskee R.F., Mosinger B., 2009. Release of endogenous opioids from duodenal enteroendocrine cells requires Trpm5. Gastroenterology 137, 598–606, https://doi.org/10.1053/j.gast....
19. Kowalski C., Giruad P., 1993. Dopamine decreases striatal enkephalin turnover and proenkephalin messenger RNA abundance via D2 receptor activation in primary striatal cell cultures. Neuroscience 53, 665–672, https://doi.org/10.1016/0306-4....
20. Lang M.E., Davison J.S., Bates S.L., Meddings J.B., 1996. Opioid receptors on guinea-pig intestinal crypt epithelial cells. J. Physiol. 497, 161–171, https://doi.org/10.1113/jphysi....
21. Lewin M.J., 1992. The somatostatin receptor in the GI tract. Annu. Rev. Physiol. 54, 455–468, https://doi.org/10.1146/annure....
22. Lightman S.L., Young W.S.III., 1987. Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal. Nature 328, 643–645, https://doi.org/10.1038/328643....
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J., 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
24. Makowska K., 2019. Changes in the expression of somatostatin (SOM) in nerve fibers of gastrointestinal mucosa in dogs with inflammatory bowel disease (IBD). Med. Case Rep. 5, 1:90.
25. Montgomery L.E., Tansey E.A., Johnson C.D., Roe S.M., Quinn J.G., 2016. Autonomic modification of intestinal smooth muscle contractility. Adv. Physiol. Educ. 40, 104–109, https://doi.org/10.1152/advan.....
26. Owczarek D., Cibor D., Mach T., Ciesla A., Pierzchala-Koziec K., Salapa K., 2011. Met-enkephalins in patients with inflammatory bowel diseases. Adv. Med. Sci. 56, 158–164, https://doi.org/10.2478/v10039....
27. Parker C.E., Nguyen T.M., Segal D., MacDonald J.K., Chande N., 2018. Low dose naltrexone for induction of remission in Crohn’s disease. Cochrane Database Syst. Rev. 4:CD010410, https://doi.org/10.1002/146518....
28. Pierzchała-Koziec K., 2012. Ghrelin is multifaceted hormone. Acta Biol. Cracov. Ser. Zool. 54, 5–9.
29. Pierzchała K., Van Loon G.R., 1990. Plasma native and peptidase-derivable Met-enkephalin responses to restraint stress in rats. Adaptation to repeated restraint. J. Clin. Invest. 85, 861–873, https://doi.org/10.1172/JCI114....
30. Scerif M., Goldstone A.P., Korbonits M., 2011. Ghrelin in obesity and endocrine diseases. Mol. Cell Endocrinol. 340, 15–25, https://doi.org/10.1016/j.mce.....
31. Skulsky E.M., Nadir B.S., Osman I., Baghdoyan H.A., Lydic R., 2007. Microdialysis delivery of morphine to the hypoglossal nucleus of Wistar rat increases hypoglossal acetylcholine release. Sleep 30, 566–573, https://doi.org/10.1093/sleep/....
32. Sobczak M., Sałaga M., Storr M.A., Fichna J., 2014. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. J. Gastroenterol. 49, 24–45, https://doi.org/10.1007/s00535....
33. Takeuchi T., Tanaka K., Nakajima H., Matusi M., Azuma Y-T., 2006. M2 and M3 muscarinic receptors are involved in enteric nerve-mediated contraction of the mouse ileum: findings obtained with muscarinic-receptor knockout mouse. Am. J. Physiol. Gastrointest. Liver. Physiol. 292, G154–164, https://doi.org/10.1152/ajpgi.....
34. Thompson G.L., Canals M., Poole D.P., 2014. Biological redundancy of endogenous GPCR ligands in the gut and the potential for endogenous functional selectivity. Front. Pharmacol. 5, 262, https://doi.org/10.3389/fphar.....
ISSN:1230-1388